CRX rs28936683: Understanding This Rare Genetic Variant

What each genotype means

What is the rs28936683 Variant?

The rs28936683 variant is a specific change in the DNA sequence of the CRX gene. In genetics, a variant like this represents a single point in the genome where the DNA code differs between individuals. This particular variant is classified as a missense mutation, meaning it results in a change to the amino acid sequence of the protein produced by the gene. Located on chromosome 19, the CRX gene provides the blueprint for a transcription factor, a type of protein that acts like a master switch to turn other genes on or off. Because this variant alters the structure of this critical protein, researchers study it to understand how it might disrupt the normal development or maintenance of the retina, the light-sensitive tissue at the back of the eye.

The Role of the CRX Gene

The CRX gene, which stands for cone-rod homeobox, is vital for the health of the human eye. It encodes a transcription factor that is specifically active in photoreceptor cells—the rods and cones that allow us to see in low light and perceive color, respectively. During development, the CRX protein helps guide the differentiation of these cells, ensuring they mature correctly. In adulthood, it continues to play a maintenance role, regulating the expression of genes necessary for the ongoing function and survival of photoreceptors. When the CRX gene is mutated, the resulting protein may fail to regulate these processes effectively, which can lead to the gradual degeneration of photoreceptor cells and subsequent vision loss.

Research and Clinical Associations

Scientific research has linked various mutations in the CRX gene to a spectrum of inherited retinal diseases, including Leber congenital amaurosis (LCA) and cone-rod dystrophy (CORD). LCA is a severe, early-onset condition characterized by significant vision loss from infancy, while CORD typically involves a progressive loss of color vision and visual acuity. While some CRX variants are clearly pathogenic, the evidence for many specific variants remains limited. Researchers often classify these as variants of uncertain significance (VUS) because it is difficult to prove that a single genetic change is the sole cause of a patient's symptoms without extensive functional testing. Consequently, while rs28936683 is noted in clinical catalogs, its specific impact on individual health can vary, and it is often studied in the context of broader retinal degeneration research.

Population Frequency

The rs28936683 variant is considered exceedingly rare across global population databases. Because it is not a common polymorphism found in the general public, it is rarely encountered in large-scale genomic studies. Its presence is typically identified only in clinical settings where individuals are being tested for specific, rare inherited eye conditions. Because the variant is so uncommon, there is very little data regarding its frequency across different ancestral groups. In the context of genetic testing, the rarity of a variant is often one factor that clinicians consider when evaluating whether it might be contributing to a patient's clinical presentation, as rare variants are more likely to be associated with specific, uncommon genetic disorders.

Navigating Genetic Information

If you have received information about this variant through genetic testing, it is important to understand that this information is for educational purposes and does not constitute a medical diagnosis. Genetic variants in the CRX gene are complex, and their clinical significance can depend on many factors, including family history and other genetic or environmental influences. You cannot use this information to predict specific health outcomes or to make decisions about medical care on your own. If you are concerned about your vision or the results of a genetic test, the most appropriate step is to consult with a genetic counselor or an ophthalmologist who specializes in inherited retinal diseases. These professionals can help interpret your results in the context of your personal health history and provide guidance on appropriate clinical follow-up.

Frequently asked questions

Sources & further reading

Related variants in CRX